BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 26058345)

  • 1. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project.
    Martín-Martínez MA; Castañeda S; González-Juanatey C; Sánchez-Alonso F; García-Gómez C; López-González R; Babío-Herraiz J; Juan-Mas A; Moreno-Gil MP; Sánchez-González CO; Romera-Baurés M; Pinto-Tasende JA; Tornero-Molina J; Fábregas-Canales D; Llorca J; González-Gay MA;
    Clin Exp Rheumatol; 2019; 37(5):731-739. PubMed ID: 30620291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.
    Urruticoechea-Arana A; Martín-Martínez MA; Castañeda S; Piedra CA; González-Juanatey C; Llorca J; Díaz-Gonzalez F; González-Gay MA;
    Arthritis Res Ther; 2015 Aug; 17(1):211. PubMed ID: 26271333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up.
    Martín-Martínez MA; Castañeda S; Sánchez-Alonso F; García-Gómez C; González-Juanatey C; Sánchez-Costa JT; Belmonte-López MA; Tornero-Molina J; Santos-Rey J; Sánchez González CO; Quesada E; Moreno-Gil MP; Cobo-Ibáñez T; Pinto-Tasnde JA; Babío-Herráez J; Bonilla G; Juan-Mas A; Manero-Ruiz FJ; Romera-Baurés M; Bachiller-Corral J; Chamizo-Carmona E; Uriarte-Ecenarro M; Barbadillo C; Fernández-Carballido C; Aurrecoechea E; Möller-Parrera I; Llorca J; González-Gay MA;
    Rheumatology (Oxford); 2021 Jun; 60(6):2906-2915. PubMed ID: 33254222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project.
    Valero-Jaimes JA; López-González R; Martín-Martínez MA; García-Gómez C; Sánchez-Alonso F; Sánchez-Costa JT; González-Juanatey C; Revuelta-Evrad E; Díaz-Torné C; Fernández-Espartero C; Pérez-García C; Torrente-Segarra V; Sánchez-Nievas G; Pérez-Sandoval T; Font-Ugalde P; García-Vivar ML; Aurrecoechea E; Maiz-Alonso O; Valls-García R; Miranda-Filloy JA; Llorca J; Castañeda S; Gonzalez-Gay MA
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
    Nissen CB; Hørslev-Petersen K; Primdahl J
    Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis.
    Mok CC; Ko GT; Ho LY; Yu KL; Chan PT; To CH
    Arthritis Care Res (Hoboken); 2011 Feb; 63(2):195-202. PubMed ID: 20890981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk profiles in inflammatory joint disease entities.
    Wibetoe G; Ikdahl E; Rollefstad S; Olsen IC; Bergsmark K; Kvien TK; Salberg A; Soldal DM; Bakland G; Lexberg Å; Fevang BT; Gulseth HC; Haugeberg G; Semb AG
    Arthritis Res Ther; 2017 Jul; 19(1):153. PubMed ID: 28673314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Han C; Robinson DW; Hackett MV; Paramore LC; Fraeman KH; Bala MV
    J Rheumatol; 2006 Nov; 33(11):2167-72. PubMed ID: 16981296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.
    Gulati AM; Semb AG; Rollefstad S; Romundstad PR; Kavanaugh A; Gulati S; Haugeberg G; Hoff M
    Ann Rheum Dis; 2016 May; 75(5):819-24. PubMed ID: 25814652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
    John H; Kitas G
    Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
    Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
    Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
    Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
    Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.
    Kiadaliri A; Dell'Isola A; Englund M
    Clin Rheumatol; 2024 Jan; 43(1):81-85. PubMed ID: 37639149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
    Radner H; Lesperance T; Accortt NA; Solomon DH
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden.
    Landgren AJ; Dehlin M; Jacobsson L; Bergsten U; Klingberg E
    RMD Open; 2021 May; 7(2):. PubMed ID: 34031261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of metabolic syndrome in patients with psoriatic arthritis.
    Pehlevan S; Yetkin DO; Bahadır C; Goktay F; Pehlevan Y; Kayatas K; Ince N
    Metab Syndr Relat Disord; 2014 Feb; 12(1):43-8. PubMed ID: 24206172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
    Eriksson JK; Jacobsson L; Bengtsson K; Askling J
    Ann Rheum Dis; 2017 Feb; 76(2):364-370. PubMed ID: 27283333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
    Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.